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Abstract  33 
 34 
Previous studies have demonstrated that cocoa intake decreased Th2 immune-related antibodies in 35 
rats. In consequence, we aimed to study in depth this cocoa action, particularly assessing its effect on a 36 
rat model of food allergy (FA) and also on an anaphylactic response. The involvement of the intestinal 37 
immune system was analyzed to allow the action mechanisms to be investigated. The role of cocoa 38 
flavonoids in the anti-allergic properties of cocoa was also established.  39 
Brown Norway rats were fed either a reference diet or diets containing conventional cocoa (CC) or 40 
non-fermented cocoa (NFC). FA to ovalbumin (OVA) was induced and, later, an anaphylactic 41 
response was provoked.  42 
As expected, the synthesis of anti-OVA IgE and other Th2-related antibodies was inhibited by CC 43 
diet. In addition, the release of mast cell protease II after anaphylaxis was partially prevented by CC, 44 
although other variables were not modified. The CC diet also attenuated the increase of some Th2-45 
related cytokines released from mesenteric lymph node and spleen cells, and modulated the intestinal 46 
gene expression of molecules involved in allergic response. These results demonstrated the local and 47 
systemic influence of CC diet. The effects of the NFC diet were weaker than those of CC, suggesting 48 
that cocoa components other than flavonoids play a role in cocoa’s action. 49 
In conclusion, by acting on intestinal and systemic immune functions, a cocoa-enriched diet in rats 50 
exhibited a protective effect against FA and partially against anaphylaxis, making this a food of high 51 
interest to the fields of health and immunonutrition. 52 





 In a rat model of food allergy, we demonstrated here that a diet with conventional 56 
cocoa prevented completely the synthesis of specific IgE, which play a key role in 57 
allergy, and was able to modulate specific IgG antibodies associated with Th2-58 
immune response. 59 
 Cocoa intake showed a protective role against the increase of Th2-cytokines, such as 60 
IL-5 and IL-13, released from mesenteric lymph node cells, and also prevented the 61 
increase of IL-4 in spleen cells, a result that could explain the high inhibition of IgE 62 
synthesis by the this diet.  63 
 After anaphylaxis induction, the release of mast cell protease II was greatly prevented 64 
by the cocoa diet. In addition, this diet down-regulated intestinal and mast cell 65 
protease and IgE receptor gene expression. 66 
 Anaphylactic response assessed by body temperature, hematocrit, intestinal 67 
permeability and motor activity was not prevented in cocoa fed animals, with the 68 
exception of a faster recuperation of hematocrit.  69 
 Results obtained with a diet with purer cocoa flavonoids allow the suggestion that 70 
flavonoids were only partially responsible for the reported effects, other compounds in 71 




1. Introduction  74 
Cocoa has a relatively high content of antioxidant flavonoids, mainly flavanols such as epicatechin, 75 
catechin and procyanidins [1]. Its immunomodulatory effects in healthy rats have been demonstrated 76 
by its modification of the composition and functionality of spleen B and T lymphocytes [2], its 77 
promotion of T cell maturation [3] and its ability to decrease the intestinal IgM and IgA secretion [4]. 78 
Moreover, in ovalbumin-(OVA) immunized rats, the intake of a cocoa-enriched diet decreases serum 79 
specific IgG1, IgG2a, IgG2c and IgM concentrations [5].  80 
Allergy is an immune disease mainly mediated by IgE. After allergen intake and processing, specific T 81 
lymphocytes differentiate and expand into T helper (Th) 2 cells characterized by producing cytokines 82 
such as IL-4, IL-5, IL-10, and IL-13, which switch B cell antibody production against the allergen to 83 
predominantly IgE [6]. IgE coats the surface of mast cells, binding to the high-affinity IgE receptors 84 
(FcεRI), producing their sensitization. Later exposure to the same allergen triggers the mast cell 85 
releasing of mediators such as histamine, proteases and cytokines, which result in allergic symptoms 86 
involving the skin, respiratory and gastrointestinal systems or even the nervous and cardiovascular 87 
systems [7]. Several studies suggest the preventive role of flavonoids in allergic reactions. Thus, in a 88 
respiratory allergy model in rodent, chrysin, baicalin or quercitin can suppress the airway hyper-89 
responsiveness, decrease the inflammatory cells in the bronchoalveolar lavage fluid and mucus 90 
production, as well as decrease the total or specific IgE synthesis [8–10]. In mice with allergic rhinitis, 91 
the administration of KOB03, mainly containing baicalin, improves the rhinitis symptoms and inhibits 92 
the mast cell activation, the release of allergic mediators and the production of inflammatory cytokines 93 
[11]. In addition, we have previously reported the inhibitory effect of a cocoa-enriched diet on specific 94 
IgE and other Th2-related antibodies in intraperitoneally (i.p.) sensitized allergic Brown Norway rats 95 
[12]. In humans, a clinical trial in persistent allergic rhinitis patients demonstrates the ability of apple 96 
polyphenols to ameliorate clinical symptoms [13]. Since these effects are mainly reported in 97 
respiratory allergy, it is important to establish the influence of flavonoid intake on food allergy (FA), 98 
which, with its increasing prevalence, is a major public health problem in developed countries. Food 99 
allergy involves the intestinal immune system and the loss of oral tolerance, and can lead to an 100 
anaphylactic response [14]. In this regard, the prevention of the development of FA in mice through 101 
the intake of apple polyphenol has been described, providing protection against a decrease in body 102 
temperature, inhibiting histamine release and decreasing the specific IgE antibody levels [15–17]. 103 
Based on these antecedents, the present study aimed to study in depth the anti-allergic properties of 104 
cocoa, in particular assessing its effect on a rat model of FA and also its repercussions on an 105 
anaphylactic response. The intestinal immune system was also analyzed to allow the action 106 
mechanisms to be investigated. Finally, the role of cocoa flavonoids on the anti-allergic actions of 107 
cocoa was established. 108 
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2. Material and methods 109 
2.1 Diets 110 
Three types of diets were elaborated (Table 1): reference diet with no polyphenols (RF) and two 111 
cocoa-enriched diets either including conventional cocoa (CC) or cocoa flavonoids from non-112 
fermented cocoa (NFC), both containing 0.4% of polyphenols. The CC diet was made up from Natural 113 
Forastero cocoa containing 40.18 mg/g of polyphenols provided by Idilia Foods SL (formerly 114 
Nutrexpa S.L., Barcelona, Spain) The NFC diet was elaborated with an ethanol extract of non-115 
fermented and non-roasted cocoa beans containing 510 mg/g of polyphenols (Naturex, Avignon, 116 
France). The addition of 100 g/kg of conventional Natural Forastero cocoa and 8.7 g/kg of NFC was 117 
established in order to obtain final isocaloric diets with 0.4% of polyphenols and the same proportion 118 
of macronutrients as the reference diet. The diets were prepared from a basal mix diet and particular 119 
components were supplied by Teklad Global Diets (Harlan, Indianapolis, IN, USA) and provided ad 120 
libitum. 121 
2.2 Induction of food allergy and anaphylaxis 122 
Dams with 14-day-old Brown Norway (BN) rat litters (50% male, 50% female) were obtained from 123 
Janvier (Saint-Berthevin, France). After a one-week acclimation period, the weaned rats were 124 
randomized into four groups: healthy sham rats fed RF diet (H-RF), FA rats fed RF diet (FA-RF), FA 125 
rats fed CC diet (FA-CC) and FA rats fed NFC diet
 
(FA-NFC) (Fig. 1). The FA induction was 126 
performed as previously described [18]. Briefly, rats received i.p.50 g of ovalbumin (OVA, grade V, 127 
Sigma-Aldrich, Madrid, Spain) as allergen, 2.5 mg of alum (Imject®; Pierce, IL, USA) and 50 ng of 128 
toxin from Bordetella pertussis (tBp; Sigma-Aldrich) as adjuvants. Fourteen days later, animals daily 129 
received 1 mL of OVA solution in mineral water (1 mg per rat) by oral gavage for one week. H-RF 130 
group received 1 mL of vehicle. Every 2-3 days water intake and food consumption were registered, 131 
body weight was measured and blood samples were collected weekly (Fig. 1). 132 
Five days after finishing the oral OVA administration, the animals were fasted overnight and then 133 
received 1 mL of 200 mg/mL of OVA orally in order to induce an anaphylactic response (AR). Blood 134 
was collected at 0, 30, 60, 90, and 120 min from the saphenous vein to determine hematocrit and 135 
RMCP-II concentration. In order to assess the intestinal barrier integrity [19], 30 min after the 136 
challenge each rat received 1 mL of β-lactoglobulin (βLG, Sigma-Aldrich) (100 mg/rat) by oral 137 
gavage. During AR, rectal temperature was measured using a digital thermometer (Acorn
®
 Temp TC 138 
Thermocouple Thermometer, Oakton, IL, USA). Three days after the AR induction rats were 139 
sacrificed and biological samples were obtained (Fig. 1). 140 
The experimental design was repeated three times in order to acquire representative results from a 141 
sufficient number of animals per group (n=4 per group in each experiment, n=12 per group at the end 142 
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of the study). Experimental procedures were approved by the Ethical Committee for Animal 143 
Experimentation at the University of Barcelona (ref.494/14). 144 
2.3 Motor activity measurement  145 
Motor activity was determined as previously described with slight modifications [20]. Briefly, two 146 
motor activity measurements were performed to establish the basal movements and the changes 147 
induced by AR: the first was measured 24 h before anaphylactic induction, and the second 148 
immediately after the oral challenge. Motor activity movement counts were recorded using time 149 
frames from 1 min to 21 min. To stimulate rat movements, 10 min after the beginning of the 150 
measurement, the lights were turned off for 6 min and then turned on until the end of the 151 
measurement. The results refer to the movements in three time phases: pre-darkness, darkness and 152 
post-darkness, as well as the entire period. The area under the curve (AUC) for the 21 min period, and 153 
the percentage of motor activity decrease after AR induction with respect to the basal measurement in 154 
each studied phase and the whole period were calculated. 155 
2.4 Quantification of mast cell mediators and intestinal permeability during anaphylaxis 156 
In serum samples obtained during the AR, RMCP-II concentration was quantified using an ELISA set 157 
(Moredun Animal Health, Edinburgh, UK) as previously described [20]. To assess intestinal 158 
permeability, βLG was quantified in serum obtained during AR by ELISA as previously reported [18]. 159 
2.5 Sample processing  160 
Three days after the AR induction, mesenteric lymph nodes (MLN) and spleen were dissected for 161 
immediate lymphocyte isolation. From the middle of the small intestine, a piece (0.5 cm) was kept in 162 
RNA later
®
 (Ambion, Life Technologies, Austin, USA) until gene expression analysis and another 163 
little piece was separated for histology. Gut washes were obtained from the distal half of the small 164 
intestine for quantification of total and specific IgA [18]. 165 
2.6 Determination of cytokines released from MLN and spleen cells  166 
Spleen and MLN cell suspensions were obtained and cultured (2.5 × 10
6
/mL) with or without OVA 167 
(10 µg/mL) as previously described [18]. After 96 h, supernatants were collected to assess 168 
representative Th1 and Th2 cytokine concentrations using the Bio-Plex Pro™ Rat Cytokine Th1/Th2 169 
Assay (Bio-Rad, Madrid, Spain) according to the manufacturer’s instructions. Analysis was carried 170 
out with the Bio-Plex® MAGPIX™ Multiplex Reader and the Bio-Plex Data Pro™ software (Bio-171 




2.7 Quantification of metabolic hormones in serum 174 
At the end of the study, serum concentrations of ghrelin, glucagon, glucagon-like peptide (GLP)-1 and 175 
leptin were determined using the Bio-Plex Pro™ Diabetes Assay (Bio-Rad) as detailed above. The 176 
limits of quantification can be found in the Supporting Information.  177 
2.8 Quantification of gene expression in small intestine  178 
For RNA isolation, small intestine pieces were processed as previously described [18]. Two 179 
micrograms of total RNA were converted to cDNA using random hexamers (Applied Biosystems 180 
(AB), CA, USA). The specific PCR TaqMan® primers and probes (AB) used were: Iga (331943, 181 
made to order), Fcer1a (Rn00562369_m1, inventoried (I)), Mcpt2 (Rn00756479_g1, I), Tgfb1 182 
(Rn00572010_m1, I), Muc2 (Rn01498195_m1, I) and Ocldn (Rn00580064_m1, I). Quantification of 183 
the genes of interest was normalized to the endogenous control actb (Rn00667869_m1, I). Real-time 184 
PCR assays were performed in duplicate using an ABI Prism 7900HT sequence detection system 185 
(AB).  186 
The amount of target mRNA relative to actb expression and relative to H-RF animals was calculated 187 
using the 2
-Ct
 method, as previously described [21]. Ct is the cycle number at which the fluorescence 188 
signal of the PCR product crosses an arbitrary threshold set within the exponential phase of the PCR.  189 
2.9 Small intestine histological analysis 190 
Histological samples were processed as previously described [4]. Next, sections were stained with 191 
hematoxylin-eosin and goblet cells were counted from each complete villus observed using light 192 
microscopy. 193 
2.10 Anti-OVA antibody quantification 194 
Anti-OVA IgG1, IgG2a, IgG2b and IgA antibody concentrations were quantified using an indirect 195 
ELISA, and OVA-specific IgE concentration by an antibody-capture ELISA as previously described 196 
[18]. The relative concentration of each anti-OVA antibody isotype is expressed in arbitrary units 197 
(AU), which were assigned using a positive pool of OVA-immunized rat serum as standard. The 198 
AU/mL assigned were 100,000 AU/mL for IgG1 and IgG2a, 10,000 AU/mL for IgG2b, and 10 199 
AU/mL for IgE. For intestinal anti-OVA IgA, since no positive samples were available, data are 200 
expressed by means of OD values. Intestinal IgA antibodies were determined by sandwich ELISA as 201 
previously described [22].  202 
2.11 Statistical analysis 203 
The software package IBM SPSS Statistics 20 (SPSS Inc., USA) was used. Levene’s and 204 
Kolmogorov-Smirnov tests were applied to assess variance equality and normal distribution, 205 
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respectively. Two-way ANOVA tests were used to study the effect of group and group x time 206 
interaction. The motor activity data were analyzed by two-way ANOVA for repeated measures 207 
considering the group and time as the interacting factors followed by Bonferroni’s post hoc test. 208 
To analyze the results from antibodies, metabolic hormones, RMCP-II, βLG and cytokine 209 
concentrations, body weight, food consumption, water intake, decrease of movements, AUC from 210 
motor activity measurement, hematocrit, body temperature, relative gene expression, and number of 211 
goblet cells, non-parametric tests (Kruskal–Wallis and Mann–Whitney U) were used due to non-212 




3. Results 215 
3.1 Body weight, food and water intake and metabolic hormones  216 
At the end of the study, body weight from the FA-RF group was similar to that of the H-RF (Table 2). 217 
However, in the FA-CC group but not in the FA-NFC group the body weight was lower (p<0.05). 218 
Food and water intake was monitored throughout the study and no significant differences among 219 
groups were found (Table 2).  220 
The last day of the study, serum ghrelin concentrations showed no significant differences between 221 
groups (Table 2). However, GLP-1 and leptin levels were significantly increased by the FA induction 222 
(p<0.05). Both increases were prevented by the CC diet, and it also produced a decrease in the 223 
glucagon levels (p<0.05). The NFC diet prevented only the GLP-1 increase. 224 
3.2 Serum specific anti-OVA antibodies 225 
Sera from the H-RF group did not contain anti-OVA antibodies of any isotype (Fig. 2). The i.p. OVA 226 
administration induced the synthesis of anti-OVA IgG1, IgG2a, IgG2b and IgE antibodies that were 227 
already detectable on day 7. The oral administration of the allergen on days 14-21, boosted the 228 
antibody synthesis of IgG1 and IgG2a in the FA-RF group by about 30 times (Fig. 2A and 2B). These 229 
increases were completely prevented by the CC diet. In animals from the FA-NFC group, anti-OVA 230 
IgG1 and IgG2a antibodies only increased 8-9 fold at day 21 and were significantly lower than those 231 
in the FA-RF group.  232 
The FA induction produced lower specific IgG2b antibody production than IgG1 and IgG2a isotypes 233 
and the oral administration of OVA on days 14-21 did not increase it (Fig. 2C). Nevertheless, at day 234 
14, their levels were significantly higher in the FA-CC group than in the FA-RF rats. 235 
Regarding specific IgE antibodies (Fig. 2D), the oral administration of OVA from day 14 to day 21 236 
increased anti-OVA IgE fourfold in the FA-RF group. The CC diet prevented the synthesis of 237 
anti-OVA IgE, whereas the NFC diet reduced these antibodies when oral administration was finished.  238 
3.3 Intestinal IgA and specific anti-OVA IgA antibodies 239 
At the end of the study, the levels of total intestinal IgA were similar between the H-RF and FA-RF 240 
groups (Fig. 2E). In both groups fed with cocoa flavonoids, total IgA was significantly decreased, the 241 
strongest effect being found in FA-CC animals. Intestinal anti-OVA IgA (Fig. 2F), significantly rose 242 
in the FA-RF group and this increase was prevented by the CC diet but not by the NFC diet. 243 
3.4 Assessment of anaphylaxis 244 
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Changes in motor activity, body temperature, hematocrit, serum RMCP-II and βLG concentrations 245 
were determined immediately after oral challenge to assess anaphylaxis. 246 
Basal values of motor activity showed that FA-CC animals had a lower number of movements in 247 
comparison with the rest of the groups (p<0.05; Fig. 3A-B). After AR induction, all the FA animals 248 
showed a significant decrease in the number of movements (p<0.05; Fig. 3C-D). To avoid the effect of 249 
lower basal motor activity, the percentage of decrease between basal and post-AR induction was 250 
calculated for the whole period and for each phase (Fig. 3E). There was a significant and similar 251 
decrease of almost 70% in the motor activity of all the FA groups (in the pre-darkness and the whole 252 
studied period). 253 
Before the induction of anaphylaxis, the basal body temperature was similar in all groups and around 254 
37.8 ± 0.04 ºC (mean ± S.E.M). During AR, it dropped in the three groups with FA (p<0.05) without 255 
differences due to diet (Fig. 4A). Inversely, hematocrit increased in the three FA groups in comparison 256 
with H-RF animals (p<0.05; Fig. 4B), but after 2 h of the oral challenge, both cocoa groups partially 257 
recovered healthy values (p<0.05). In parallel, serum RMCP-II concentration (Fig. 4C) rose after the 258 
oral challenge in the FA-RF group, and this increase was partially prevented in the FA-CC group. 259 
Nevertheless, intestinal permeability augmented in all animals with FA, regardless of the diet 260 
(Fig. 4D). 261 
3.5 Intestinal structure and small intestine gene expression 262 
Intestinal histology (Fig. 5A) in the animals of the FA-RF group did not reveal a clear inflammation 263 
with the exception of certain crypt elongation. Both cocoa flavonoid diets induced slight villous 264 
atrophy (Fig. 5A) and a lower number of goblet cells (Fig. 5B).  265 
The relative gene expression of IgA, FcεRI, RMCP-II, TGF-β1, occludin and mucin 2 was quantified 266 
in the small intestine (Fig. 6). In the FA-RF group, the FA induction produced a significant increase in 267 
the IgA gene expression in comparison with the H-RF group (p<0.05), whereas both cocoa diets 268 
prevented this increase (p<0.05); the FA-CC group even reduced the IgA mRNA levels with respect to 269 
the H-RF animals (p<0.05). In addition, the FA-CC group, but not the FA-NFC group, also had lower 270 
gene expression of FcRI, RMCP-II and TGF-β1 in comparison with H-RF and FA-RF animals 271 
(p<0.05). With regard to the mRNA levels of occludin and mucin 2, no significant changes were 272 
observed due to FA or cocoa diets.  273 
3.6 Cytokine production by MLN and spleen cells 274 
MLN cells from the FA-RF group produced significantly higher levels of IL-4, IL-5 and IL-13 in 275 
comparison with cells from the H-RF group (p<0.05) (Fig. 7A). Both cocoa diets prevented the 276 
increase in IL-5 and IL-13 (p<0.05 vs. FA-RF group). In addition, the MLN cytokine pattern from 277 
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animals fed cocoa diets underwent several other changes. Cells from the FA-CC group decreased the 278 
secretion of IL-1α, IL-1β and IFN- with respect to the H-RF and FA-RF group. The FA-NFC group 279 
decreased IL-1α and GM-CSF secretion in comparison with the two RF groups (p<0.05). 280 
Regarding the cytokine production from splenocytes (Fig. 7B), FA induction significantly increased 281 
the release of IL-2, IL-4 and IL-13 in the FA-RF group (p<0.05 vs. H-RF group). However, cells from 282 
FA-CC rats did not increase IL-2 and IL-4, and showed higher IL-6 production (p<0.05 vs. RF 283 
groups). Splenocytes from the FA-NFC group showed a similar increase in IL-4 and IL-13 and higher 284 
levels of IL-6, IL-10 and IFN- (p<0.05) than the FA-RF group. 285 
Cytokines released from MLN and spleen cells in non-stimulated conditions were lower than those 286 




4. Discussion 289 
Previous studies concerning the effect of a cocoa diet on the immune system in rats reveal the ability 290 
of a cocoa diet to attenuate serum and intestinal immunoglobulin synthesis [2–5,23,24]. In addition, a 291 
diet containing 10% of cocoa in a rat allergy model induced by only an i.p. immunization 292 
demonstrates an important inhibition in Th2-specific antibodies [12]. These results prompted us to 293 
ascertain both the effect of this diet on a FA model and its repercussions on anaphylactic response 294 
[18]. In addition, the study of local (intestine and MLN) and systemic (spleen) lymphoid tissues 295 
allowed the action mechanisms to be investigated. Finally, in order to learn about the role of cocoa 296 
flavonoids, a diet containing more pure polyphenols obtained from unfermented cocoa was included.  297 
In a rat model of FA, we demonstrated here that a diet with CC that started at the same time as allergy 298 
induction was also able to modulate those specific IgG antibodies associated with Th2-immune 299 
response (IgG1 and IgG2a), without affecting those related to Th1 cell activation (IgG2b). More 300 
interestingly, CC diet in FA rats prevented completely the synthesis of specific IgE that play a key role 301 
in allergy. Although some studies using polyphenol-enriched diets show a similar effect [25,26], our 302 
results with the NFC diet on specific antibodies allow the suggestion that flavonoids are only partially 303 
responsible for the attenuating action on Th2-antibody synthesis and other compounds in CC must 304 
enhance this anti-allergy effect. In agreement with this suggestion, a previous study in healthy Lewis 305 
rats shows that a diet containing 0.8% of polyphenols from NFC produced the same 306 
immunomodulatory effect as a diet containing 0.2% of polyphenols from CC [23]. Therefore, the 307 
cocoa content of fiber and methylxanthines, which was higher in CC than in NFC, could add to or 308 
enhance the action of polyphenols. In this sense, CC contains fiber such as cellulose, hemicelluloses 309 
and pectic substances [27], that are able to modify microbiota [28] and this could eventually affect to 310 
the food sensitization process as has been described [29]. 311 
On the other hand, FA induction caused an increase in intestinal anti-allergen IgA synthesis, as 312 
quantified by protein levels and also by IgA gene expression. Although IgA is considered the first 313 
specific line of defense in protecting the intestine, it has been shown that the induction of tolerance in 314 
FA mice is associated with an inhibition of specific intestinal IgA [30]. The CC diet reduced total 315 
intestinal IgA protein and gene expression in agreement with previous studies [4,22], thus avoiding the 316 
synthesis of the specific IgA. A comparison of these results with the NFC diet again suggests that 317 
other compounds and/or particular flavonoids in the CC, which are known to change during the 318 
fermentation process [31], must play a role in its attenuating effects on the gut immune system. With 319 
regard to the mechanisms involved in CC-induced intestinal IgA decrease, we studied TGF-β1 gene 320 




In order to establish the action mechanisms of cocoa diets in FA, Th1 and Th2 cytokines were 323 
assessed in OVA-stimulated MLN and spleen cells, as representative intestinal and systemic tissues. 324 
Consistently, FA increased the release of Th2 cytokines such as IL-4, IL-5 and IL-13 from MLN cells. 325 
Although IL-4 plays an essential role in the antibody class-switching to IgE synthesis [34,35], it was 326 
not lowered in MLN from cocoa-fed animals, which agrees with previous studies on cocoa-fed allergic 327 
rats [12]. Interestingly, both cocoa diets showed a protective role against the increase of other Th2-328 
cytokines such as IL-5 and IL-13, and the CC diet also decreased the release of the Th1-cytokines 329 
IL-1α, IL-1β and IFN- from MLN cells. The modulatory activity of cocoa on these Th1 cytokines 330 
could be beneficial in FA because IL-1 has been involved in the inflammatory process of allergic 331 
diseases [36]. In spleen cells, FA also increased the release of IL-4 and IL-13. Although cocoa diets 332 
were unable to avoid the increase in IL-13, the CC diet, but not the NFC diet, prevented the increase of 333 
IL-4, a result that could explain the high inhibition of IgE synthesis by the CC diet. These results 334 
partially agree with decreased splenic IL-4 production in immunized mice fed with chrysin and 335 
apigenin [37] and suggest that particular flavonoids have different immunomodulatory properties. In 336 
addition, it must be added that the NFC diet increased the production of IL-10 in both tissues and 337 
IFN- in splenocytes, whereas it decreased the production of GM-CSF in MLN cells; on the other 338 
hand, both cocoa diets increased the levels of IL-6 in spleen cells. Taken together, these results 339 
evidence the complex modulatory effects of flavonoids and also other compounds present in cocoa on 340 
immune function. Some cytokines that promote Th2 response, IL-5 and IL-13, were inhibited by both 341 
cocoa diets in MLN, but importantly only CC was able to inhibit the IL-4 release from spleen cells, 342 
which may shed some light on the IgE-regulatory role of this diet. 343 
In this study we also focused on the intestinal changes induced by FA in the gene expression of 344 
epithelial barrier proteins, such as mucin 2 and occludin. The FA, regardless of the cocoa diets, did not 345 
modify the gene expression of either epithelial barrier proteins involved in luminal protection of the 346 
intestine. This fact must be attributed to the method of FA induction, which, unlike other models [38], 347 
does not use adjuvants such as cholera toxin. Mucin 2 is secreted by goblet cells [39] and, from the 348 
histology sections, we counted less goblet cells after CC intake, although this was not confirmed by 349 
PCR. More research should be focused on confirming these results and the mechanism involved. 350 
The most severe response of FA is anaphylaxis after allergen intake, induced by the fast degranulation 351 
of mast cells. In our FA model this can be quantified by high serum RMCP-II concentrations. We have 352 
found that this increase in RF-FA animals was greatly prevented by the CC diet, whereas NFC intake 353 
only showed a certain effect. This protective response by cocoa could be a consequence of lower 354 
specific IgE levels and also to the down-regulation of FcRI gene expression, both effects found here. 355 
In vitro studies have demonstrated the inhibitory effects of flavonoids on FcRI surface molecule or 356 
gene expression [40,41]. Although mast cells were not determined histologically in the intestine, from 357 
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these results we can hypothesize that cocoa intake would reduce mast cell accumulation in the 358 
intestine and/or down-regulate FcRI, producing, in any case, a lower RMCP-II release after allergen 359 
intake. As the NFC diet did not produce the same effects, compounds of cocoa other than flavonoids 360 
must be responsible for, or enhance, such actions. 361 
Anaphylactic response was also assessed by a drop in body temperature, and an increase in hematocrit 362 
and intestinal permeability. Surprisingly, these alterations were not prevented by either the CC or the 363 
NFC diet, with the exception of a faster recuperation of hematocrit. As body temperature fall is due to 364 
a massive vasodilatation induced by mast cell mediators [42], the recognized vasodilator properties of 365 
cocoa [43] could explain the lack of effect of cocoa intake on this variable. The anaphylactic response 366 
was also assessed through the reduction in motor activity. In fact, rats fed with CC showed a lower 367 
motor activity in basal conditions which merits further studies. Nevertheless, when the decrease 368 
percentage of motor activity after the induction of anaphylaxis was quantified, CC rats showed a 369 
similar pattern to that of FA and NFC groups. Therefore, the overall effects on anaphylactic response 370 
suggest that, although CC diet reduced the production of anti-allergen IgE, RMCP-II synthesis and 371 
down-regulated FcRI and RMCP-II gene expression, these actions were not enough to prevent the 372 
anaphylactic response after oral challenge with the allergen. 373 
Finally, although food intake did not differ among groups, the CC diet produced a decrease in the 374 
body weight without modifying food intake. The slower body weight increase was similar to that 375 
reported in healthy rats [24,28], and this fact prompted us to determine some metabolic hormones. The 376 
FA process and later induction of anaphylaxis caused increased levels of leptin and GLP-1, both 377 
prevented by CC diet. The interaction between obesity, asthma and leptin has long been studied [44], 378 
and some studies have reported the association of higher serum leptin levels with some allergic status 379 
[45,46]. In agreeing with these studies we show here that FA can also increase serum leptin in rats 380 
together with GLP-1, which has not been described in previous studies. The CC diet prevented these 381 
increases and also produced lower glucagon levels, effects that deserve further studies in line with 382 
those demonstrating the influence of cocoa diet on metabolism [47]. 383 
In conclusion, a cocoa-enriched diet suppresses the Th2 immune response, both in intestinal and 384 
systemic compartments, as evidenced in Th2-related cytokines and antibodies, and is also able to 385 
attenuate the release of mast cell mediators. These effects are stronger in CC than NFC, suggesting 386 
that components other than flavonoids take part in this response after the induction of anaphylaxis. 387 
Further studies to clarify which components present in cocoa are responsible for this action should be 388 
developed. Although cocoa seems not to have a protective role in the face of anaphylaxis, the 389 
inhibition of serum allergen-specific antibodies as well as the RMCP-II release supposes the 390 
cornerstone of its protective properties, becoming a potential nutrient in the prevention of FA and 391 
making this a food of high interest in the field of health and immunonutrition. 392 
15 
 
Acknowledgements  393 
The authors would like to thank Dr. Antoni Díez-Noguera and Dr. Trinitat Cambras for lending us the 394 
activity meters and Maria Pérez-Cano, Malén Massot-Cladera, Filipa Vicente, and Sònia Sánchez for 395 
their technical assistance.  396 
Conflict of interests  397 




 References 400 
[1] Rusconi M, Conti A. Theobroma cacao L., the food of the gods: a scientific approach beyond myths and 401 
claims. Pharmacol Res 2010;61:5–13. doi:10.1016/j.phrs.2009.08.008. 402 
[2] Ramiro-Puig E, Pérez-Cano FJ, Ramírez-Santana C, Castellote C, Izquierdo-Pulido M, Permanyer J, et 403 
al. Spleen lymphocyte function modulated by a cocoa-enriched diet. Clin Exp Immunol 2007;149:535–404 
42. doi:10.1111/j.1365-2249.2007.03430.x. 405 
[3] Ramiro-Puig E, Urpí-Sardà M, Pérez-Cano FJ, Franch À, Castellote C, Andrés-Lacueva C, et al. Cocoa-406 
enriched diet enhances antioxidant enzyme activity and modulates lymphocyte composition in thymus 407 
from young rats. J Agric Food Chem 2007;55:6431–8. doi:10.1021/jf070487w. 408 
[4] Ramiro-Puig E, Pérez-Cano FJ, Ramos-Romero S, Pérez-Berezo T, Castellote C, Permanyer J, et al. 409 
Intestinal immune system of young rats influenced by cocoa-enriched diet. J Nutr Biochem 410 
2008;19:555–65. 411 
[5] Pérez-Berezo T, Ramiro-Puig E, Pérez-Cano FJ, Castellote C, Permanyer J, Franch À, et al. Influence of 412 
a cocoa-enriched diet on specific immune response in ovalbumin-sensitized rats. Mol Nutr Food Res 413 
2009;53:389–97. doi:10.1002/mnfr.200700396. 414 
[6] Larché M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat 415 
Rev Immunol 2006;6:761–71. doi:10.1038/nri1934. 416 
[7] Amin K. The role of mast cells in allergic inflammation. Respir Med 2012;106:9–14. 417 
doi:10.1016/j.rmed.2011.09.007. 418 
[8] Jung H-S, Kim MH, Gwak N-G, Im Y-S, Lee K-Y, Sohn Y, et al. Antiallergic effects of Scutellaria 419 
baicalensis on inflammation in vivo and in vitro. J Ethnopharmacol 2012;141:345–9. 420 
doi:10.1016/j.jep.2012.02.044. 421 
[9] Du Q, Gu X, Cai J, Huang M, Su M. Chrysin attenuates allergic airway inflammation by modulating the 422 
transcription factors T-bet and GATA-3 in mice. Mol Med Rep 2012;6:100–4. 423 
doi:10.3892/mmr.2012.893. 424 
[10] Cruz EA, Reuter S, Martin H, Dehzad N, Muzitano MF, Costa SS, et al. Kalanchoe pinnata inhibits mast 425 
cell activation and prevents allergic airway disease. Phytomedicine 2012;19:115–21. 426 
doi:10.1016/j.phymed.2011.06.030. 427 
[11] Won Jung H, Jung J-K, Weon Cho C, Kang J-S, Park Y-K. Antiallergic effect of KOB03, a polyherbal 428 
medicine, on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouse and 429 
human mast cells. J Ethnopharmacol 2012;142:684–93. doi:10.1016/j.jep.2012.05.039. 430 
[12] Abril-Gil M, Massot-Cladera M, Pérez-Cano FJ, Castellote C, Franch À, Castell M. A diet enriched with 431 
cocoa prevents IgE synthesis in a rat allergy model. Pharmacol Res 2012;65:603–8. doi:doi: 432 
10.1016/j.phrs.2012.02.001. 433 
[13] Enomoto T, Nagasako-Akazome Y, Kanda T, Ikeda M, Dake Y. Clinical effects of apple polyphenols on 434 
persistent allergic rhinitis: a randomized double-blind placebo-controlled parallel arm study. J Investig 435 
Allergol Clin Immunol 2006;16:283–9. 436 
[14] Sicherer SH, Sampson HA. Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment. J 437 
Allergy Clin Immunol 2014;133:291–307; quiz 308. doi:10.1016/j.jaci.2013.11.020. 438 
17 
 
[15] Akiyama H, Sato Y, Watanabe T, Nagaoka MH, Yoshioka Y, Shoji T, et al. Dietary unripe apple 439 
polyphenol inhibits the development of food allergies in murine models. FEBS Lett 2005;579:4485–91. 440 
doi:10.1016/j.febslet.2005.07.019. 441 
[16] Zuercher AW, Holvoet S, Weiss M, Mercenier A. Polyphenol-enriched apple extract attenuates food 442 
allergy in mice. Clin Exp Allergy 2010;40:942–50. doi:10.1111/j.1365-2222.2010.03460.x. 443 
[17] Singh A, Demont A, Actis-Goretta L, Holvoet S, Lévêques A, Lepage M, et al. Identification of 444 
epicatechin as one of the key bioactive constituents of polyphenol-enriched extracts that demonstrate an 445 
anti-allergic effect in a murine model of food allergy. Br J Nutr 2014;112:358–68. 446 
doi:10.1017/S0007114514000877. 447 
[18] Abril-Gil M, Garcia-Just A, Pérez-Cano FJ, Franch À, Castell M. Development and characterization of 448 
an effective food allergy model in brown norway rats. PLoS One 2015. 449 
doi:10.1371/journal.pone.0125314. 450 
[19] Knippels LMJ, Penninks AH, Smit JJ, Houben GF. Immune-mediated effects upon oral challenge of 451 
ovalbumin-sensitized Brown Norway rats: further characterization of a rat food allergy model. Toxicol 452 
Appl Pharmacol 1999;156:161–9. 453 
[20] Abril-Gil M, Garcia-Just A, Cambras T, Pérez-Cano FJ, Castellote C, Franch À, et al. Motor activity as 454 
unbiased variable to assess anaphylactic shock in allergic rats. Exp Biol Med 2015. 455 
doi:10.1177/1535370215573393. 456 
[21] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR 457 
and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–8. 458 
[22] Massot-Cladera M, Abril-Gil M, Torres S, Franch À, Castell M, Pérez-Cano FJ. Impact of cocoa 459 
polyphenol extracts on the immune system and microbiota in two strains of young rats. Br J Nutr 460 
2014;112:1944–54. doi:10.1017/S0007114514003080. 461 
[23] Massot-Cladera M, Franch À, Castellote C, Castell M, Pérez-Cano FJ. Cocoa flavonoid-enriched diet 462 
modulates systemic and intestinal immunoglobulin synthesis in adult Lewis rats. Nutrients 2013;5:3272–463 
86. doi:10.3390/nu5083272. 464 
[24] Pérez-Berezo T, Franch A, Ramos-Romero S, Castellote C, Pérez-Cano FJ, Castell M. Cocoa-enriched 465 
diets modulate intestinal and systemic humoral immune response in young adult rats. Mol Nutr Food Res 466 
2011;55:S56–66. doi:10.1002/mnfr.201000588. 467 
[25] Cruz EA, Da-Silva SAG, Muzitano MF, Silva PMR, Costa SS, Rossi-Bergmann B. Immunomodulatory 468 
pretreatment with Kalanchoe pinnata extract and its quercitrin flavonoid effectively protects mice 469 
against fatal anaphylactic shock. Int Immunopharmacol 2008;8:1616–21. 470 
doi:10.1016/j.intimp.2008.07.006. 471 
[26] Matsumoto T, Horiuchi M, Kamata K, Seyama Y. Improvement of the antiinflammatory and antiallergic 472 
activity of Bidens pilosa L. var. radiata SCHERFF treated with enzyme (Cellulosine). J Health Sci 473 
2008;54:294–301. doi:10.1248/jhs.54.294. 474 
[27] Lecumberri E, Mateos R, Izquierdo-Pulido M, Rupérez P, Goya L, Bravo L. Dietary fibre composition, 475 
antioxidant capacity and physico-chemical properties of a fibre-rich product from cocoa (Theobroma 476 
cacao L.). Food Chem 2007;104:948–54. doi:10.1016/j.foodchem.2006.12.054. 477 
[28] Massot-Cladera M, Pérez-Berezo T, Franch A, Castell M, Pérez-Cano FJ. Cocoa modulatory effect on 478 




[29] Noval Rivas M, Burton OT, Wise P, Zhang Y, Hobson SA, Lloret MG, et al. A microbiota signature 481 
associated with experimental food allergy promotes allergic sensitization and anaphylaxis. J Allergy Clin 482 
Immunol 2013;131:201–12. doi:10.1016/j.biotechadv.2011.08.021. 483 
[30] Perrier C, Thierry A-C, Mercenier A, Corthésy B. Allergen-specific antibody and cytokine responses, 484 
mast cell reactivity and intestinal permeability upon oral challenge of sensitized and tolerized mice. Clin 485 
Exp Allergy 2010;40:153–62. doi:10.1111/j.1365-2222.2009.03329.x. 486 
[31] McShea A, Ramiro-Puig E, Munro SB, Casadesus G, Castell M, Smith MA. Clinical benefit and 487 
preservation of flavonols in dark chocolate manufacturing. Nutr Rev 2008;66:630–41. 488 
doi:10.1111/j.1753-4887.2008.00114. 489 
[32] Cazac BB, Roes J. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. 490 
Immunity 2000;13:443–51. 491 
[33] Stavnezer J, Kang J. The surprising discovery that TGF beta specifically induces the IgA class switch. J 492 
Immunol 2008;182:5–7. doi:10.4049/jimmunol.182.1.5. 493 
[34] Paludan SR. Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship. 494 
Scand J Immunol 1998;48:459–68. 495 
[35] Boothby M, Mora AL, Aronica MA, Youn J, Sheller JR, Goenka S, et al. IL-4 signaling, gene 496 
transcription regulation, and the control of effector T cells. Immunol Res 2001;23:179–91. 497 
[36] Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and 498 
interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011;127:701–21.e1–499 
70. doi:10.1016/j.jaci.2010.11.050. 500 
[37] Yano S, Umeda D, Yamashita T, Ninomiya Y, Sumida M, Fujimura Y, et al. Dietary flavones suppresses 501 
IgE and Th2 cytokines in OVA-immunized BALB/c mice. Eur J Nutr 2007;46:257–63. 502 
doi:10.1007/s00394-007-0658-7. 503 
[38] Camps-Bossacoma M, Abril-Gil M, Franch À, Pérez-Cano FJ, Castell M. Induction of a model of oral 504 
sensitization in rat. Clin Immunol Endocr Metab Drugs 2015. in press. 505 
[39] Johansson MEV, Sjövall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat 506 
Rev Gastroenterol Hepatol 2013;10:352–61. doi:10.1038/nrgastro.2013.35. 507 
[40] Yano S, Tachibana H, Yamada K. Flavones suppress the expression of the high-affinity IgE receptor 508 
FcepsilonRI in human basophilic KU812 cells. J Agric Food Chem 2005;53:1812–7. 509 
doi:10.1021/jf047929d. 510 
[41] Nakano N, Nishiyama C, Tokura T, Nagasako-Akazome Y, Ohtake Y, Okumura K, et al. Procyanidin 511 
C1 from apple extracts inhibits Fc epsilon RI-mediated mast cell activation. Int Arch Allergy Immunol 512 
2008;147:213–21. doi:10.1159/000142044. 513 
[42] Simons FER. Anaphylaxis. J Allergy Clin Immunol 2010;125:S161–81. doi:10.1016/j.jaci.2009.12.981. 514 
[43] Sudano I, Flammer AJ, Roas S, Enseleit F, Ruschitzka F, Corti R, et al. Cocoa, blood pressure, and 515 
vascular function. Curr Hypertens Rep 2012;14:279–84. doi:10.1007/s11906-012-0281-8. 516 
[44] Yuksel H, Sogut A, Yilmaz O, Onur E, Dinc G. Role of adipokines and hormones of obesity in 517 
childhood asthma. Allergy Asthma Immunol Res 2012;4:98–103. doi:10.4168/aair.2012.4.2.98. 518 
[45] Guler N, Kirerleri E, Ones U, Tamay Z, Salmayenli N, Darendeliler F. Leptin: does it have any role in 519 
childhood asthma? J Allergy Clin Immunol 2004;114:254–9. doi:10.1016/j.jaci.2004.03.053. 520 
19 
 
[46] Sood A, Ford ES, Camargo Jr CA. Association between leptin and asthma in adults. Thorax 521 
2006;61:300–5. doi:10.1136/thx.2004.031468. 522 
[47] Ali F, Ismail A, Kersten S. Molecular mechanisms underlying the potential antiobesity-related diseases 523 





Figures  527 
Figure 1. Experimental design. Time-course of the experimental protocol including the points of 528 





Figure 2. Concentrations of serum anti-OVA antibodies during the study: A) IgG1, B) IgG2a, 532 
C) IgG2b, D) IgE, and E) intestinal IgA and F) intestinal anti-OVA IgA. White bars or  represent 533 
H-RF group, black bars or  represent FA-RF group, white-striped bars or  represent FA-CC group 534 
and grey bars or   represent FA-NFC group. Shadow period corresponds to oral administration of 535 
OVA in FA groups. Results are expressed as mean ± SEM (n = 12). *p<0.05 vs. H-RF group, and 536 

p<0.05 vs. FA-RF group and 
#




Figure 3. Motor activity for 21-min period: A) basal motor activity and B) AUC assessed 24 h before 539 
the AR induction; C) motor activity and D) AUC assessed immediately after AR induction; E) 540 
percentage of motor activity decrease after AR induction referring to pre-darkness, darkness, post-541 
darkness and the whole period. White bars or  represent H-RF group, black bars or  represent FA-542 
RF group, white-striped bars or  represent FA-CC group and grey bars or   represent FA-NFC 543 
group. In A and C, shadow period corresponds to darkness. Results are expressed as mean ± SEM (n = 544 
12). *p<0.05 vs. H-RF group, and 

p<0.05 vs. FA-RF group and 
#




Figure 4. Variables measured during 2 h after anaphylaxis induction: A) changes in body temperature, 547 
B) hematocrit, C) serum RMCP-II and D) βLG concentrations. White bars or  represent H-RF 548 
group, black bars or  represent FA-RF group, white-striped bars or  represent FA-CC group and 549 
grey bars or   represent FA-NFC group. Results are expressed as mean ± SEM (n = 12). *p<0.05 vs. 550 
H-RF group, and 

p<0.05 vs. FA-RF group and 
#





Figure 5. Intestinal structure. A) Representative intestinal sections from H-RF, FA-RF, FA-CC and 554 
FA-NFC groups stained with hematoxilin-eosin (100x magnification) and B) number of goblet cells. 555 
Results are expressed as mean ± SEM (n = 6). *p<0.05 vs. H-RF group, and 






Figure 6. Relative gene expression of several molecules in small intestine. Expression levels were 559 
normalized using actb as the endogenous housekeeping gene and were expressed as percentage in 560 
comparison with the H-RF group, which was considered as 100% gene expression. White bars 561 
represent H-RF group, black bars represent FA-RF group, white-striped bars represent FA-CC group 562 
and grey bars represent FA-NFC group. Results are expressed as mean ± SEM (n = 12). *p<0.05 vs. 563 
H-RF group, and 

p<0.05 vs. FA-RF group and 
#





Figure 7. Cytokine production from A) mesenteric lymph nodes and B) spleen cells after OVA-567 
stimulation. White bars represent H-RF group, black bars represent FA-RF group, white-striped bars 568 
represent FA-CC group and grey bars represent FA-NFC group. Results are expressed as mean ± SEM 569 
(n = 6-8). *p<0.05 vs. H-RF group, and 

p<0.05 vs. FA-RF group and 
#





Table 1. Composition of reference (RF), conventional cocoa (CC) and non-fermented (NFC) cocoa 573 
diets 574 
Components RF diet (g/kg) CC diet (g/kg) NFC diet (g/kg) 
Casein 124.3 99.5 124.3 
L-Cystine 1.8 1.4 1.8 
Corn starch 419.5 432.1 419.5 
Maltodextrin 148.6 116.8 148.6 
Sucrose 102.7 108.7 102.7 
Soybean oil 38.3 26.2 38.3 
Cellulose 50 24.5 50 
Minerals 35.3 27.8 35.3 
Vitamins 2.0 7.2 2.0 
Choline bitartrate 9.1 2.0 9.1 
Cocoa powder - 100 8.7 
   
        Protein - 22 1.13 
        Carbohydrate - 16 0.82 
        Lipid - 11 0.56 
        Fiber (insoluble/soluble) - 34 (25.5/8.5) 1.75 (1.31/0.44) 
        Total polyphenols - 4 4 
Polyphenols provided by 
cocoa powder: 
   
Catechin - 0.073 0.040 
Epicatechin - 0.204 0.689 
Isoquercetin - 0.0053 n.d. 
Quercetin - 0.0029 n.d. 
Procyanidin B1 - n.d. 0.127 
Procyanidin B2 - 0.167 0.356 
Total procyanidins - n.d. 3.897 




Table 2. Body weight, food consumption, water intake and metabolic hormones in H-RF, FA-RF, FA-577 
CC and FA-NFC groups. Results are expressed as mean ± SEM (n = 6-12). 578 
 H-RF FA-RF FA-CC FA-NFC 
Weight day 0 (g) 36.4 ± 1.01 35.8 ±0.76 36.1 ± 0.79 35.1 ± 0.86 
Weight day 30 (g) 116.0 ± 9.31 103.0 ± 4.59 81.3 ± 4.23*






 204.5± 20.36 185.3 ± 10.17 176.1 ±  15.16 202.1 ± 10.79 
Water intake (mL/rat)
a
 306.0 ± 14.09 297.3 ± 23.50 325.0 ± 28.92 333.8 ± 16.82 
Metabolic hormones     
Ghrelin (ng/mL) 19.61 ± 4.30 10.27 ± 2.03 12.98 ± 3.72 13.94 ± 2.12 
Glucagon (pg/mL) 115.08 ± 7.82 127.70 ± 10.75 92.04 ± 2.99*

 126.65 ± 12.72
#
 
GLP-1 (pg/mL) 79.67 ± 9.03 137.55 ± 10.99* 91.35 ± 4.71

 80.95 ± 16.60

 
Leptin (pg/mL) 367.62 ± 80.22 586.91 ± 88.74* 367.24 ± 53.45





p<0.05 vs. H-RF group  

p<0.05 vs. FA-RF group 
#
p<0.05 vs. FA-CC group. 
a





Appendix A. Supplementary data 581 
Lower (LLOQ) and upper limits of quantification (ULOQ) for cytokines and metabolic hormones 582 
according to the Bioplex-Pro assay applied  583 
Cytokines (pg/mL) 
 LLOQ ULOQ 
IL-1α 7.82 31953.56 
IL-1β 8.26 31999.96 
IL-2 145.58 32188.31 
IL-4 0.84 15954.37 
IL-5 7.79 8068.31 
IL-6 35.36 32600.93 
IL-10 32.31 31999.8 
IL-2p70 1.64 32202.1 
IL-13 6.87 34692.34 
GM- CSF 1.71 30927.75 
IFN-γ 8.51 33143.52 
TNF-α 1.55 8171.98 
Metabolic hormones (pg/mL) 
Ghrelin 159.58 155595.25 
Glucagon 23.43 1316.37 
GLP-1 8.44 1999.39 
Leptin 123.73 130750.77 
 584 
